1. Home
  2. CYTK vs COLB Comparison

CYTK vs COLB Comparison

Compare CYTK & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$78.68

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

COLB

Columbia Banking System Inc.

HOLD

Current Price

$30.52

Market Cap

8.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
COLB
Founded
1997
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
8.6B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CYTK
COLB
Price
$78.68
$30.52
Analyst Decision
Strong Buy
Hold
Analyst Count
19
14
Target Price
$89.26
$31.46
AVG Volume (30 Days)
1.7M
2.6M
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
5.08%
EPS Growth
N/A
N/A
EPS
N/A
0.66
Revenue
$13,368,000.00
$177,000,000.00
Revenue This Year
$7.37
$31.52
Revenue Next Year
$310.19
$2.90
P/E Ratio
N/A
$45.24
Revenue Growth
N/A
18.94
52 Week Low
$31.99
$22.12
52 Week High
$80.20
$32.70

Technical Indicators

Market Signals
Indicator
CYTK
COLB
Relative Strength Index (RSI) 62.37 54.50
Support Level $59.07 $28.28
Resistance Level $79.66 $31.11
Average True Range (ATR) 3.20 0.69
MACD 0.51 0.05
Stochastic Oscillator 83.65 54.56

Price Performance

Historical Comparison
CYTK
COLB

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

Share on Social Networks: